CLINICAL_TRIALS
trial_result
· 2026-04-21
Clinical Trial Update: ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial testing an antiviral treatment for cytomegalovirus in Major Depressive Disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Laureate Institute for Brain Research, Inc. | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED